ATLASImpact BioMedical (IBO) earnings date: Nov 6, 2026
Impact BioMedical (IBO) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 6, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on IBO
| Last price | $4.41 (+16.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±7.4% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Impact BioMedical stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Impact BioMedical reports on Nov 6, 2026. One email the day before, with ATLAS’s read on Impact BioMedical. You can switch it off at any time.
Alert me before IBO reportsFree to start. Creating an account takes under a minute.
Notify me when Impact BioMedical reports
Track IBO free Add Impact BioMedical to a free ATLAS watchlist and see its next report date in one place.
IBO earnings at a glance
| Next report (confirmed) | Fri, Nov 6, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Jul 8, 2026 · Beat |
| Beat rate (last 4 reports) | 4 of 4 (100%) |
| Average EPS surprise | +24.5% |
| Average move around a report | ±2.2% (last 4) |
| Sector | Healthcare · Biotechnology |
Impact BioMedical earnings history: last 4 reports
Impact BioMedical last reported on Jul 8, 2026: EPS of $0.05 against an estimate of $0.04 (+25.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 8, 2026 | $0.04 | $0.05 | +25.0% | Beat | +0.2% |
| Apr 29, 2026 | $3.69 | $4.10 | +11.1% | Beat | +3.0% |
| Mar 31, 2026 | $0.59 | $0.66 | +11.9% | Beat | +5.0% |
| Oct 13, 2025 | $0.02 | $0.03 | +50.0% | Beat | -0.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for IBO
See the fair value, the probability range and the earnings history of Impact BioMedical on its ATLAS page.
Impact BioMedical (IBO) stock analysisPlans from €3.99 a month.
Impact BioMedical earnings: frequently asked questions
When does Impact BioMedical (IBO) report earnings?
Impact BioMedical is scheduled to report on Friday, November 6, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does IBO beat earnings estimates?
Of its last 4 reports with a recorded result, Impact BioMedical beat the EPS estimate 4 times; the average surprise was +24.5%. Past results do not predict the next one.
How much does IBO move around earnings?
Over its last 4 reports the stock moved an average of 2.2% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Impact BioMedical beat earnings estimates last quarter?
Impact BioMedical last reported on Jul 8, 2026: EPS of $0.05 against an estimate of $0.04 (+25.0% surprise), a beat.
How much does IBO usually move in a day?
On a normal trading day the ATLAS model puts IBO’s one-day range at about ±7.4%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 6, 2026
Educational information, not investment advice. Disclaimer